S&P 500 Index Outlook: Top Three Catalysts for US Stocks This Week
This S&P 500 Index outlook explores the top catalysts for US stocks this week, including US consumer and producer inflation.
Stocks · News reference
This FormFactor Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday
Wall Street analysts upgraded EDU, MKTX, and FORM stocks. Check out their ratings on Benzinga's analyst ratings page before buying EDU.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Consumer Tech (Aug 31-Sep 4): NVIDIA Buys World's Largest Open AI Developer, Trump Claims Total Control On Hormuz & More
President Donald Trump recently claimed the U.S. has “total control” over the Strait. NVIDIA acquire Hugging Face for $12.93 billion.
Earnings Volatility Watch: Oracle And Adobe Report, But the Wild Swings Belong to Smaller Names
Oracle and Adobe headline the week, both down about 20% in 2026, yet the biggest implied earnings moves belong to InnovAge, SailPoint and eight others.
Shares of software companies are trading lower after August's hotter-than-expected payrolls report increased expectations that the Federal Reserve could raise interest rates at its next meeting. A stronger U.S. dollar and higher rate expectations are weighing on growth stocks by reducing investor appetite for higher-risk assets.
Guggenheim Maintains Buy on Avalo Therapeutics, Lowers Price Target to $48
Guggenheim analyst Yatin Suneja maintains Avalo Therapeutics (NASDAQ:AVTX) with a Buy and lowers the price target from $50 to $48.
HC Wainwright & Co. Maintains Buy on Avalo Therapeutics, Lowers Price Target to $30
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Avalo Therapeutics (NASDAQ:AVTX) with a Buy and lowers the price target from $35 to $30.